Profil bibliographique

Л. З. Болиева

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

42Publications signalées

477Citations signalées

1Affiliations récentes

Institutions déclarées

Domaines associés

Legal and Regulatory AnalysisLinguistic, Cultural, and Literary StudiesMilitary Technology and StrategiesPharmacogenetics and Drug MetabolismEicosanoids and Hypertension Pharmacology

Publications récentes

2025 articleOpenAlex

Results of an open-label, randomized, multicenter, comparative study of clinical efficacy and safety of Pulmibud drug and Pulmicort drug in patients with partially controlled and uncontrolled persistent bronchial asthma

Л. З. Болиева, K.S. Manko, S.M. Kryzhanovskiy

0 citationsJournal of Respiratory Medicine

Accès ouvert 2025 articleOpenAlex

Prevalence of AOX1 and CYP1A2 gene polymorphisms associated with response to favipiravir therapy in novel coronavirus infection COVID-19 among ethnic groups of the North Caucasus

А. Т. Лейнсоо, Н. П. Денисенко, Sh. P. Abdullaev, С. Н. Тучкова et autres

1 citationPharmacy & Pharmacology

Accès ouvert 2025 articleOpenAlex

All-Russian observational non-interventional program on the study of the efficacy of Subetta in real-world clinical practice in patients with prediabetes (SILA)

А. В. Зилов, Л. З. Болиева

2 citationsMeditsinskiy sovet = Medical Council

Accès ouvert 2024 articleOpenAlex

Current opportunities for the prevention and treatment of carbohydrate metabolism disorders

А. В. Зилов, Л. З. Болиева

2 citationsMeditsinskiy sovet = Medical Council

Accès ouvert 2024 articleOpenAlex

The impact of infection on micronutrient status: the role of vitamins and trace elements in defense against infection

S. L. Babak, И. Г. Бакулин, Л. З. Болиева, А.В. Горелов et autres

0 citationsInfectious diseases News Opinions Training

Accès ouvert 2024 articleOpenAlex

The use of acetylsalicylic acid medications in the management of common cold and influenza in adults: safety implications

S. L. Babak, И. Г. Бакулин, Л. З. Болиева, А.В. Горелов et autres

0 citationsInfectious diseases News Opinions Training

Accès ouvert 2022 articleOpenAlex

Structure of the distribution of genetic determinants of the efficacy and safety of non-steroidal anti-inflammatory drugs in the Russian population: focus on CYP2C8, PTGS1 and PTGS2

Н. П. Денисенко, Sh. P. Abdullaev, К. А. Акмалова, Zhannet A. Sozaeva et autres

1 citationModern Rheumatology Journal

Accès ouvert 2021 articleOpenAlex

Effects of dapagliflozin on mortality in patients with chronic kidney disease: a pre-specified analysis from the DAPA-CKD randomized controlled trial

Hiddo J.L. Heerspink, C. David Sjöström, Niels Jongs, Glenn M. Chertow et autres

122 citationsEuropean Heart Journal

Accès ouvert 2020 articleOpenAlex

Analysis of carrying clinically significant allelic variants of TPMT and DPYD genes associated with the response to drug therapy in cancer practice among 9 ethnic groups of the Russian Federation

К. Б. Мирзаев, Denis S. Fedorinov, К. А. Акмалова, Sh. P. Abdullaev et autres

4 citationsTerapevticheskii arkhiv

2020 articleOpenAlex

Interethnic differences in the Prevalence of Main Cardiovascular Pharmacogenetic Biomarkers

К. Б. Мирзаев, Sh. P. Abdullaev, К. А. Акмалова, Jeannette Sozaeva et autres

12 citationsPharmacogenomics

2019 articleOpenAlex

Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis

Д. А. Сычев, Sh. P. Abdullaev, К. Б. Мирзаев, Kristina Ryzhikova et autres

11 citationsMolecular Biology Reports

2019 articleOpenAlex

Consensus of the Russian Scientific Medical Society of Therapists (RSMST) Expert Council 'Improving Treatment Outcomes of Respiratory Tract Infections'

Martynov Ai, A.G. Malyavin, М. В. Журавлева, Л. З. Болиева et autres

2 citationsRussian Journal of Preventive Medicine

Profil ORCID Notice OpenAlex

BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, ROR et la Banque mondiale, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune donnée externe enregistrée en base. Sources et limites.